PUT - SPRINTER OPEN END - MERCK & CO. | Market Closed - Deutsche Boerse AG 13:52:42 2024-06-26 EDT | ||
| 1.45 EUR | +5.84% |
|
| Current month | -32.87% | ||
| 1 month | -16.67% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Chart
MERCK & CO., INC.
Latest news about MERCK & CO., INC.
More news
| Date | Price | Change |
|---|---|---|
| 24-06-26 | 1.45 | +5.84% |
| 24-06-25 | 1.37 | -5.52% |
| 24-06-24 | 1.45 | -13.69% |
| 24-06-21 | 1.68 | +0.60% |
| 24-06-20 | 1.67 | -8.74% |
Delayed Quote Deutsche Boerse AG
Last update June 26, 2024 at 01:52 pm
More quotesStatic data
| Product type | Knock-Out without Stop Loss |
|---|---|
| Buy / Sell | PUT |
| Underlying | MERCK & CO., INC. |
| Issuer | 
Vontobel
|
| WKN | VM9YVQ |
| ISIN | DE000VM9YVQ1 |
| Date issued | 2024-02-07 |
| Strike | 147.5 $ |
| Maturity | Unlimited |
| Parity | 10 : 1 |
| Emission price | 2.06 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 2.59 € |
|---|---|
| Lowest since issue | 1.31 € |
Company Profile
Merck & Co., Inc. specializes in the development, production, and marketing of therapeutic products and vaccines sold under prescription. Net sales break down by activity as follows:
- sale of pharmaceutical products (69.7%): for treating hypertension, osteoporosis, atherosclerosis, respiratory, bacterial and fungal, ophthalmologic, and urological diseases, acute migraine, hair loss in men, etc.;
- sale of vaccines (18%);
- sale of animal health products (9.4%);
- other (2.9%).
Net sales are distributed geographically as follows: the United States (45.9%), Europe/Middle East/Africa (24.5%), China (8.8%), Japan (6.1%), Asia/Pacific (6.1%), Latin America (4.3%) and other (4.3%).
Sector
-
Consensus: Merck & Co., Inc.
Sell
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
131.5
USD
Average target price
142.7
USD
Spread / Average Target
+8.50%
- Stock Market
- Certificates
- Certificat
